Wednesday, November 11, 2026
The top medical stories of the day, as they ran.
Morning edition
15 stories
- 1FDA requires GLP-1 makers to warn of rare vision-loss riskDrugs and FDA · 5 outlets
- 2Experts meet to assess U.S. measles-elimination statusInfectious disease · 4 outlets
- 3FDA approves Bayer’s Sunharbo to reduce recurrent stroke riskDrugs and FDA · 3 outlets
- 4Oura agrees to acquire Counsel Health for $625 millionIndustry · 4 outlets
- 5Congo reports 11,042 cases in its deadliest Ebola outbreakOutbreaks · 3 outlets
- 6Beam says base-edited sickle cell therapy met goal in trialDrugs and FDA · 2 outlets
- 7PepGen reports early Phase 2 results for myotonic dystrophy drugDrugs and FDA · 3 outlets
- 8Democrats ask drugmakers to disclose Trump pricing agreementsHealth policy · 3 outlets
- 9Analysis finds three antidepressants performed better at preventing relapseResearch · 2 outlets
- 10Ruiz says Medicare for All is unrealistic as Sanders presses coverage expansionHealth policy · 2 outlets
- 11Family Farmstead Dairy recalls all cheddar products over possible Listeria contaminationRecalls · 1 outlet
- 12Oyster raises $60 million to develop tau-targeting drugs for Alzheimer’sIndustry · 2 outlets
- 13FDA grants accelerated approval to elranatamab for multiple myelomaDrugs and FDA · 1 outlet
- 14FDA grants accelerated approval to dostarlimab for dMMR solid tumorsDrugs and FDA · 1 outlet
- 15FDA approves afamitresgene autoleucel for advanced synovial sarcomaDrugs and FDA · 1 outlet